CiteULike is a free online bibliography manager. Register and you can start organising your references online.

Genentech's new parADigm Export

Science-Business eXchange, Vol. 2, No. 8. (26 February 2009), pp. 1-5.

Citation Format

[Posts]

View FullText article


ajaymalik's tags for this article

regen_neuro scibx

X Reviews [Write a review of this article]

X Find related articles from these CiteULike users

X Find related articles with these CiteULike tags

X Posting History

X Abstract

A study by a team at Genentech Inc. proposes a new mechanism for Alzheimer's disease pathogenesis by outlining a process that could be an early step in the neurodegenerative disorder.1 The work also identifies a trio of new AD targets, which the company is pursuing with preclinical programs. The study suggests that the previously ignored amino-terminal portion of amyloid precursor protein (APP), called N-APP, might be the main culprit behind AD. APP is a transmembrane protein that gives rise to N-APP and the much more commonly known beta-amyloid (Abeta), a fragment that forms the amyloid fibers and plaques that are hallmarks of AD, although the precise role of those fibers and plaques in disease pathology is unclear.2


X BibTeX record

X RIS record


Privacy Statement | Terms & Conditions
CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.